Matheus Jannuzzi Moreira de Mendonça, “Tirzepatide vs. Semaglutide in Type 2 Diabetes and Obesity: A Systematic Review and Meta-Analysis of Metabolic Efficacy, Weight Loss, and Cardiovascular Safety”, Braz. J. Implantol. Health Sci., vol. 7, nº 2, p. 388–415, fev. 2025.